Logo

GXAI

Gaxos.ai Inc.

GXAI

Gaxos.ai Inc. • NASDAQ
$1.31 ▼ -0.76% (-0.01)
Market Cap $9.33 M
52w High $7.50
52w Low $1.00
Dividend Yield 0%
P/E -3.36
Volume 31.95K
Outstanding Shares 7.12M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $498.271K ▲ $1.755M ▲ $-1.001M ▼ -200.99% ▲ $-0.14 ▼ $-1.082M ▼
Q2-2025 $170.971K ▲ $1.097M ▼ $-749.388K ▲ -438.313% ▲ $-0.11 ▲ $-768.015K ▲
Q1-2025 $23.732K ▲ $1.386M ▲ $-1.192M ▼ -5.022K% ▲ $-0.17 ▼ $-1.202M ▼
Q4-2024 $1.304K ▼ $900.698K ▼ $-832.404K ▲ -63.835K% ▼ $-0.12 ▲ $-883.988K ▲
Q3-2024 $2.704K $908.573K $-864.41K -31.968K% $-0.61 $-891.679K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $13.173M ▼ $14.286M ▼ $451.871K ▼ $14.095M ▼
Q2-2025 $14.246M ▼ $15.4M ▼ $505.45K ▲ $15.016M ▼
Q1-2025 $14.888M ▼ $16.104M ▼ $500.748K ▲ $15.649M ▼
Q4-2024 $16.766M ▲ $17.025M ▲ $401.507K ▼ $16.629M ▲
Q3-2024 $6.844M $7.119M $404.907K $6.715M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-1.001M ▼ $-1.106M ▼ $301.506K ▲ $0 $-804.781K ▲ $-1.128M ▼
Q2-2025 $-824.572K ▲ $-716.86K ▲ $-135.516K ▲ $0 $-852.376K ▲ $-738.96K ▲
Q1-2025 $-1.232M ▼ $-1.297M ▼ $-10.529M ▼ $0 ▼ $-11.827M ▼ $-1.82M ▼
Q4-2024 $-838.49K ▲ $-768.231K ▼ $-774.869K ▼ $10.713M ▲ $9.17M ▲ $-790.131K ▼
Q3-2024 $-864.41K $-674.299K $695K $2.835M $2.856M $-524.3K

Five-Year Company Overview

Income Statement

Income Statement The income statement shows an extremely early-stage company with essentially no meaningful revenue reported so far and ongoing losses at the per‑share level. This is typical of a business still building products and markets rather than one operating at scale. The pattern suggests Gaxos.ai is funding development and go‑to‑market efforts ahead of revenue, with any recent wellness and AI‑tool traction still too small or too new to transform the overall picture. Profitability is not yet in sight, and the business model remains in the validation phase rather than the harvest phase.

Balance Sheet

Balance Sheet The balance sheet is very light. Assets and cash are tiny, and there is effectively no debt. On the positive side, the company is not burdened by leverage. On the risk side, the financial cushion appears thin, which leaves limited room for missteps or delays in scaling revenue. Equity is small, reflecting the early stage and modest capital base. Overall, the company looks financially lean but also financially fragile, with a high dependence on future capital raises or rapid revenue growth to support operations.

Cash Flow

Cash Flow Reported cash flow figures are minimal, which fits a very small, asset‑light operation. Day‑to‑day spending is likely focused on salaries, product development, and marketing rather than heavy investment in physical assets or infrastructure. While this keeps capital needs lower, it also means the company’s ability to sustain negative operating cash flow depends heavily on access to new funding. Until recurring revenue grows meaningfully, cash management and financing will be central risks.

Competitive Edge

Competitive Edge Gaxos.ai is trying to carve out a niche at the intersection of AI gaming tools, digital health, and generative content. Its advantages are a lean cost base, a partner‑driven model that rides on top of major AI providers, and early traction in wellness pilots. This diversified approach reduces reliance on a single end market and could create useful cross‑selling opportunities. However, the company is extremely small and is competing in crowded spaces against well‑funded technology, gaming, and health players. Brand recognition, distribution, regulatory navigation in health, and the ability to stand out in a noisy AI landscape are all meaningful challenges.

Innovation and R&D

Innovation and R&D Innovation is the clear focus and main asset. Rather than building foundational AI models, Gaxos.ai layers its own tools and user experience on top of leading third‑party AI technologies. Its product set spans AI tools for game developers (Gaxos Labs), personalized wellness platforms (Gaxos Health and RNK Health), and a creative suite for images and video (Art‑Gen.AI). This "application‑layer" strategy lets a very small team move quickly and iterate, but also means the moat depends more on product design, integrations, data, and community than on unique core algorithms. The company is experimenting across several promising AI use cases; the key unknown is which, if any, will achieve durable product‑market fit and scale.

Summary

Overall, Gaxos.ai looks like a highly speculative, very early‑stage AI platform company: rich in ideas and product experiments, but still thin in financial history, revenue scale, and balance‑sheet strength. The main strengths are its diversified AI focus across gaming, wellness, and content creation, its partner‑driven, capital‑light model, and its early signs of traction in wellness offerings. The main risks are its tiny size, lack of established profitability, limited financial buffer, and intense competition from far larger and better‑funded players in each of its target markets. Future performance will hinge on its ability to turn promising pilots and tools into repeatable, growing revenue streams before its financial flexibility tightens further.